Release 5 R6 Ballot (3rd Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot3: Release 6 Ballot (3rd Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

4.4.1.132 4.4.1.143 ValueSet http://hl7.org/fhir/ValueSet/vaccine-code

Public Health and Emergency Response icon Work Group   Maturity Level : 1 Draft Use Context : Country: World, Not Intended for Production use World
Official URL : http://hl7.org/fhir/ValueSet/vaccine-code Version : 5.0.0 6.0.0-ballot3
active as of 2023-03-26 2025-04-01 Computable Name : VaccineAdministeredValueSet
Flags : Experimental OID : 2.16.840.1.113883.3.88.12.80.22

This value set is used in the following places:

This identifies the vaccine substance administered - CVX codes.


Generated Narrative: ValueSet vaccine-code

Last updated: 2025-04-01T12:16:37.966+11:00

Profile: Shareable ValueSet

This value set includes codes based on the following rules:

 

This expansion generated 26 Mar 2023 01 Apr 2025


This value set contains 287 concepts

ValueSet

Expansion from tx.fhir.org based on http://hl7.org/fhir/sid/cvx version 20210406 codesystem Vaccine Administered Code Set (CVX) version20231214

This value set contains 344 concepts

adenovirus, type 7 DTP DTP-Hib-Hep B HBIG RSV-MAb influenza, high dose seasonal, preservative-free Influenza, high dose seasonal   131 typhus, historical DTaP-IPV-HIB-HEP B, historical Td (adult)   129 Adenovirus types 4 and 7 RSV-MAb (new) DTaP,IPV,Hib,HepB meningococcal MCV4, unspecified formulation Meningococcal C/Y-HIB PRP Hep A, IG Rho(D)-IG meningococcal B, OMV HPV9 meningococcal, unknown serogroups influenza, trivalent, adjuvanted DTAP/IPV/HIB - non-US Rabies - IM fibroblast culture PCV10 OPV bivalent OPV ,monovalent, unspecified OPV, Unspecified Influenza, injectable, MDCK, quadrivalent, preservative HepB-CpG Hep A-Hep B, pediatric/adolescent Influenza, Southern Hemisphere
Code System Display English (English, en) Display (English)
  54   01 http://hl7.org/fhir/sid/cvx adenovirus vaccine, type 4, live, oral DTP adenovirus, type 4 diphtheria, tetanus toxoids and pertussis vaccine
  55   02 http://hl7.org/fhir/sid/cvx adenovirus OPV trivalent poliovirus vaccine, type 7, live, oral
  82   03 http://hl7.org/fhir/sid/cvx adenovirus vaccine, unspecified formulation MMR adenovirus, unspecified formulation measles, mumps and rubella virus vaccine
  24   04 http://hl7.org/fhir/sid/cvx anthrax vaccine M/R anthrax measles and rubella virus vaccine
  19   05 http://hl7.org/fhir/sid/cvx Bacillus Calmette-Guerin vaccine measles BCG measles virus vaccine
  27   06 http://hl7.org/fhir/sid/cvx botulinum antitoxin rubella rubella virus vaccine
  26   07 http://hl7.org/fhir/sid/cvx cholera vaccine, unspecified formulation mumps cholera, unspecified formulation mumps virus vaccine
  29   08 http://hl7.org/fhir/sid/cvx cytomegalovirus immune globulin, intravenous Hep B, adolescent or pediatric CMVIG hepatitis B vaccine, pediatric or pediatric/adolescent dosage
  56   09 http://hl7.org/fhir/sid/cvx dengue fever vaccine Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed dengue fever tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
  12   10 http://hl7.org/fhir/sid/cvx diphtheria antitoxin IPV poliovirus vaccine, inactivated
  28   11 http://hl7.org/fhir/sid/cvx diphtheria and tetanus toxoids, adsorbed for pediatric use pertussis DT (pediatric) pertussis vaccine
  20   12 http://hl7.org/fhir/sid/cvx diphtheria, tetanus toxoids and acellular pertussis vaccine diphtheria antitoxin DTaP diphtheria antitoxin
  106   13 http://hl7.org/fhir/sid/cvx diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens TIG DTaP, 5 pertussis antigens tetanus immune globulin
  107   14 http://hl7.org/fhir/sid/cvx diphtheria, tetanus toxoids and acellular pertussis vaccine, IG, unspecified formulation DTaP, immune globulin, unspecified formulation
  110   15 http://hl7.org/fhir/sid/cvx DTaP-hepatitis B and poliovirus vaccine influenza, split (incl. purified surface antigen) DTaP-Hep B-IPV influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
  50   16 http://hl7.org/fhir/sid/cvx DTaP-Haemophilus influenzae type b conjugate vaccine influenza, whole DTaP-Hib influenza virus vaccine, whole virus
  120   17 http://hl7.org/fhir/sid/cvx diphtheria, tetanus toxoids and acellular pertussis vaccine, Hib, unspecified formulation Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) conjugate unspecified formulation
  18 DTaP-Hib-IPV http://hl7.org/fhir/sid/cvx rabies, intramuscular injection rabies vaccine, for intramuscular injection RETIRED CODE
  130   19 http://hl7.org/fhir/sid/cvx Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated BCG DTaP-IPV Bacillus Calmette-Guerin vaccine
  01   20 http://hl7.org/fhir/sid/cvx DTaP diphtheria, tetanus toxoids and acellular pertussis vaccine
  22   21 http://hl7.org/fhir/sid/cvx DTP-Haemophilus influenzae type b conjugate vaccine varicella DTP-Hib varicella virus vaccine
  102   22 http://hl7.org/fhir/sid/cvx DTP- Haemophilus DTP-Hib DTP-Haemophilus influenzae type b conjugate and hepatitis b vaccine
  57   23 http://hl7.org/fhir/sid/cvx hantavirus vaccine plague hantavirus plague vaccine
  52   24 http://hl7.org/fhir/sid/cvx hepatitis A vaccine, adult dosage anthrax Hep A, adult anthrax vaccine
  83   25 http://hl7.org/fhir/sid/cvx hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule typhoid, oral Hep A, ped/adol, 2 dose typhoid vaccine, live, oral
  84   26 http://hl7.org/fhir/sid/cvx hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule cholera, unspecified formulation Hep A, ped/adol, 3 dose cholera vaccine, unspecified formulation
  31   27 http://hl7.org/fhir/sid/cvx hepatitis A vaccine, pediatric dosage, unspecified formulation botulinum antitoxin Hep A, pediatric, unspecified formulation botulinum antitoxin
  85   28 http://hl7.org/fhir/sid/cvx hepatitis A vaccine, unspecified formulation DT (pediatric) Hep A, unspecified formulation diphtheria and tetanus toxoids, adsorbed for pediatric use
  104   29 http://hl7.org/fhir/sid/cvx hepatitis A and hepatitis B vaccine CMVIG Hep A-Hep B cytomegalovirus immune globulin, intravenous
  30 http://hl7.org/fhir/sid/cvx HBIG hepatitis B immune globulin
  08   31 http://hl7.org/fhir/sid/cvx hepatitis B vaccine, pediatric or pediatric/adolescent dosage Hep A, pediatric, unspecified formulation Hep B, adolescent or hepatitis A vaccine, pediatric dosage, unspecified formulation
  42   32 http://hl7.org/fhir/sid/cvx hepatitis B vaccine, adolescent/high risk infant dosage meningococcal MPSV4 Hep B, adolescent/high risk infant meningococcal polysaccharide vaccine (MPSV4)
  43   33 http://hl7.org/fhir/sid/cvx hepatitis B vaccine, adult dosage pneumococcal polysaccharide PPV23 Hep B, adult pneumococcal polysaccharide vaccine, 23 valent
  44   34 http://hl7.org/fhir/sid/cvx hepatitis B vaccine, dialysis patient dosage RIG Hep B, dialysis rabies immune globulin
  45   35 http://hl7.org/fhir/sid/cvx hepatitis B vaccine, unspecified formulation tetanus toxoid, adsorbed Hep B, unspecified formulation tetanus toxoid, adsorbed
  58   36 http://hl7.org/fhir/sid/cvx hepatitis C vaccine VZIG Hep C varicella zoster immune globulin
  59   37 http://hl7.org/fhir/sid/cvx hepatitis E vaccine yellow fever Hep E yellow fever vaccine
  60   38 http://hl7.org/fhir/sid/cvx herpes simplex virus, type 2 vaccine rubella/mumps herpes simplex 2 rubella and mumps virus vaccine
  46   39 http://hl7.org/fhir/sid/cvx Haemophilus influenzae type b vaccine, PRP-D conjugate Japanese encephalitis SC Hib (PRP-D) Japanese Encephalitis Vaccine SC
  47   40 http://hl7.org/fhir/sid/cvx Haemophilus influenzae type b vaccine, HbOC conjugate rabies, intradermal injection Hib (HbOC) rabies vaccine, for intradermal injection
  48   41 http://hl7.org/fhir/sid/cvx Haemophilus influenzae type b vaccine, PRP-T conjugate typhoid, parenteral Hib (PRP-T) typhoid vaccine, parenteral, other than acetone-killed, dried
  49   42 http://hl7.org/fhir/sid/cvx Haemophilus influenzae type b vaccine, PRP-OMP conjugate Hep B, adolescent/high risk infant Hib (PRP-OMP) hepatitis B vaccine, adolescent/high risk infant dosage
  17   43 http://hl7.org/fhir/sid/cvx Haemophilus influenzae type b vaccine, conjugate unspecified formulation Hep B, adult Hib, unspecified formulation hepatitis B vaccine, adult dosage
  51   44 http://hl7.org/fhir/sid/cvx Haemophilus influenzae type b conjugate and Hepatitis B vaccine Hep B, dialysis Hib-Hep hepatitis B vaccine, dialysis patient dosage
  61   45 http://hl7.org/fhir/sid/cvx human immunodeficiency virus vaccine Hep B, unspecified formulation HIV hepatitis B vaccine, unspecified formulation
  118   46 http://hl7.org/fhir/sid/cvx human papilloma virus vaccine, bivalent Hib (PRP-D) HPV, bivalent Haemophilus influenzae type b vaccine, PRP-D conjugate
  62   47 http://hl7.org/fhir/sid/cvx human papilloma virus vaccine, quadrivalent Hib (HbOC) HPV, quadrivalent Haemophilus influenzae type b vaccine, HbOC conjugate
  86   48 http://hl7.org/fhir/sid/cvx immune globulin, intramuscular Hib (PRP-T) IG Haemophilus influenzae type b vaccine, PRP-T conjugate
  87   49 http://hl7.org/fhir/sid/cvx immune globulin, intravenous Hib (PRP-OMP) IGIV Haemophilus influenzae type b vaccine, PRP-OMP conjugate
  14   50 http://hl7.org/fhir/sid/cvx immune globulin, unspecified formulation DTaP-Hib IG, unspecified formulation DTaP-Haemophilus influenzae type b conjugate vaccine
  111   51 http://hl7.org/fhir/sid/cvx influenza virus vaccine, live, attenuated, for intranasal use Hib-Hep B influenza, live, intranasal Haemophilus influenzae type b conjugate and Hepatitis B vaccine
  15   52 http://hl7.org/fhir/sid/cvx influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE Hep A, adult influenza, split (incl. purified surface antigen) hepatitis A vaccine, adult dosage
  16   53 http://hl7.org/fhir/sid/cvx influenza virus vaccine, whole virus typhoid, parenteral, AKD (U.S. military) influenza, whole typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
  88   54 http://hl7.org/fhir/sid/cvx influenza virus vaccine, unspecified formulation adenovirus, type 4 influenza, unspecified formulation adenovirus vaccine, type 4, live, oral
  123   55 http://hl7.org/fhir/sid/cvx influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) adenovirus, type 7 influenza, H5N1-1203 adenovirus vaccine, type 7, live, oral
  10   56 http://hl7.org/fhir/sid/cvx poliovirus vaccine, inactivated dengue fever tetravalent IPV dengue fever vaccine, tetravalent
  02   57 http://hl7.org/fhir/sid/cvx trivalent poliovirus vaccine, live, oral hantavirus OPV hantavirus vaccine
  89   58 http://hl7.org/fhir/sid/cvx poliovirus vaccine, unspecified formulation Hep C polio, unspecified formulation hepatitis C vaccine
  39   59 http://hl7.org/fhir/sid/cvx Japanese Encephalitis Vaccine SC Hep E Japanese encephalitis SC hepatitis E vaccine
  63   60 http://hl7.org/fhir/sid/cvx Junin virus vaccine herpes simplex 2 Junin virus herpes simplex virus, type 2 vaccine
  64   61 http://hl7.org/fhir/sid/cvx leishmaniasis vaccine HIV leishmaniasis human immunodeficiency virus vaccine
  65   62 http://hl7.org/fhir/sid/cvx leprosy vaccine HPV, quadrivalent leprosy human papilloma virus vaccine, quadrivalent
  66   63 http://hl7.org/fhir/sid/cvx Lyme disease vaccine Junin virus Lyme disease Junin virus vaccine
  03   64 http://hl7.org/fhir/sid/cvx measles, mumps and rubella virus vaccine leishmaniasis MMR leishmaniasis vaccine
  04   65 http://hl7.org/fhir/sid/cvx measles and rubella virus vaccine leprosy M/R leprosy vaccine
  94   66 http://hl7.org/fhir/sid/cvx measles, mumps, rubella, and varicella virus vaccine Lyme disease MMRV Lyme disease vaccine
  67 http://hl7.org/fhir/sid/cvx malaria vaccine malaria vaccine
  05   68 http://hl7.org/fhir/sid/cvx measles virus vaccine melanoma measles melanoma vaccine
  68   69 http://hl7.org/fhir/sid/cvx melanoma vaccine parainfluenza-3 melanoma parainfluenza-3 virus vaccine
  32   70 http://hl7.org/fhir/sid/cvx meningococcal polysaccharide vaccine (MPSV4) Q fever meningococcal MPSV4 Q fever vaccine
  103   71 http://hl7.org/fhir/sid/cvx meningococcal C conjugate vaccine RSV-IGIV meningococcal C conjugate respiratory syncytial virus immune globulin, intravenous
  114   72 http://hl7.org/fhir/sid/cvx meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) rheumatic fever meningococcal MCV4P rheumatic fever vaccine
  108   73 http://hl7.org/fhir/sid/cvx meningococcal ACWY vaccine, unspecified formulation Rift Valley fever meningococcal ACWY, unspecified formulation Rift Valley fever vaccine
  07   74 http://hl7.org/fhir/sid/cvx mumps virus vaccine rotavirus, tetravalent mumps rotavirus, live, tetravalent vaccine
  69   75 http://hl7.org/fhir/sid/cvx parainfluenza-3 virus vaccine vaccinia (smallpox) parainfluenza-3 vaccinia (smallpox) vaccine
  11   76 http://hl7.org/fhir/sid/cvx pertussis vaccine Staphylococcus bacterio lysate pertussis Staphylococcus bacteriophage lysate
  23   77 http://hl7.org/fhir/sid/cvx plague Tick-borne encephalitis vaccine (non-US) plague Tick-borne encephalitis vaccine (non-US)
  33   78 http://hl7.org/fhir/sid/cvx pneumococcal polysaccharide vaccine, 23 valent tularemia vaccine pneumococcal polysaccharide PPV23 tularemia vaccine
  100   79 http://hl7.org/fhir/sid/cvx pneumococcal conjugate vaccine, 7 valent vaccinia immune globulin pneumococcal conjugate PCV 7 vaccinia immune globulin
  109   80 http://hl7.org/fhir/sid/cvx pneumococcal vaccine, unspecified formulation VEE, live pneumococcal, unspecified formulation Venezuelan equine encephalitis, live, attenuated
  70   81 http://hl7.org/fhir/sid/cvx Q fever vaccine VEE, inactivated Q fever Venezuelan equine encephalitis, inactivated
  18   82 http://hl7.org/fhir/sid/cvx rabies vaccine, for intramuscular injection RETIRED CODE adenovirus, unspecified formulation rabies, intramuscular injection adenovirus vaccine, unspecified formulation
  40   83 http://hl7.org/fhir/sid/cvx rabies vaccine, for intradermal injection Hep A, ped/adol, 2 dose rabies, intradermal injection hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
  90   84 http://hl7.org/fhir/sid/cvx rabies vaccine, unspecified formulation Hep A, ped/adol, 3 dose rabies, unspecified formulation hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
  72   85 http://hl7.org/fhir/sid/cvx rheumatic fever vaccine Hep A, unspecified formulation rheumatic fever hepatitis A vaccine, unspecified formulation
  73   86 http://hl7.org/fhir/sid/cvx Rift Valley fever vaccine IG Rift Valley fever immune globulin, intramuscular
  34   87 http://hl7.org/fhir/sid/cvx rabies immune globulin IGIV RIG immune globulin, intravenous
  119   88 http://hl7.org/fhir/sid/cvx rotavirus, live, monovalent vaccine influenza, unspecified formulation rotavirus, monovalent influenza virus vaccine, unspecified formulation
  122   89 http://hl7.org/fhir/sid/cvx rotavirus vaccine, polio, unspecified formulation rotavirus, poliovirus vaccine, unspecified formulation
  116   90 http://hl7.org/fhir/sid/cvx rotavirus, live, pentavalent vaccine rabies, unspecified formulation rotavirus, pentavalent rabies vaccine, unspecified formulation
  74   91 http://hl7.org/fhir/sid/cvx rotavirus, live, tetravalent vaccine typhoid, unspecified formulation rotavirus, tetravalent typhoid vaccine, unspecified formulation
  71   92 http://hl7.org/fhir/sid/cvx respiratory syncytial virus immune globulin, intravenous VEE, unspecified formulation RSV-IGIV Venezuelan equine encephalitis vaccine, unspecified formulation
  93 http://hl7.org/fhir/sid/cvx RSV-MAb respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
  06   94 http://hl7.org/fhir/sid/cvx rubella virus vaccine MMRV rubella measles, mumps, rubella, and varicella virus vaccine
  38   95 http://hl7.org/fhir/sid/cvx rubella and mumps virus vaccine TST-OT tine test rubella/mumps tuberculin skin test; old tuberculin, multipuncture device
  76   96 http://hl7.org/fhir/sid/cvx Staphylococcus bacteriophage lysate TST-PPD intradermal Staphylococcus bacterio lysate tuberculin skin test; purified protein derivative solution, intradermal
  113   97 http://hl7.org/fhir/sid/cvx tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) TST-PPD tine test Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed tuberculin skin test; purified protein derivative, multipuncture device
  09   98 http://hl7.org/fhir/sid/cvx tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) TST, unspecified formulation Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed tuberculin skin test; unspecified formulation
  115   99 http://hl7.org/fhir/sid/cvx tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed RESERVED - do not use Tdap RESERVED - do not use
  35   100 http://hl7.org/fhir/sid/cvx tetanus toxoid, adsorbed pneumococcal conjugate PCV 7 pneumococcal conjugate vaccine, 7 valent
  112   101 http://hl7.org/fhir/sid/cvx tetanus toxoid, unspecified formulation typhoid, ViCPs typhoid Vi capsular polysaccharide vaccine
  77   102 http://hl7.org/fhir/sid/cvx tick-borne encephalitis vaccine DTP-Hib-Hep B tick-borne encephalitis DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
  13   103 http://hl7.org/fhir/sid/cvx tetanus immune globulin meningococcal C conjugate TIG meningococcal C conjugate vaccine
  95   104 http://hl7.org/fhir/sid/cvx tuberculin skin test; old tuberculin, multipuncture device Hep A-Hep B TST-OT tine test hepatitis A and hepatitis B vaccine
  96   105 http://hl7.org/fhir/sid/cvx tuberculin skin test; purified protein derivative solution, intradermal vaccinia (smallpox) diluted TST-PPD intradermal vaccinia (smallpox) vaccine, diluted
  97   106 http://hl7.org/fhir/sid/cvx tuberculin skin test; purified protein derivative, multipuncture device DTaP, 5 pertussis antigens TST-PPD tine test diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
  98   107 http://hl7.org/fhir/sid/cvx tuberculin skin test; DTaP, unspecified formulation TST, diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
  78   108 http://hl7.org/fhir/sid/cvx tularemia vaccine meningococcal ACWY, unspecified formulation meningococcal ACWY vaccine, unspecified formulation
  91   109 http://hl7.org/fhir/sid/cvx typhoid vaccine, pneumococcal, unspecified formulation typhoid, pneumococcal vaccine, unspecified formulation
  25   110 http://hl7.org/fhir/sid/cvx typhoid vaccine, live, oral DTaP-Hep B-IPV typhoid, oral DTaP-hepatitis B and poliovirus vaccine
  41   111 http://hl7.org/fhir/sid/cvx typhoid vaccine, parenteral, other than acetone-killed, dried influenza, live, intranasal typhoid, parenteral influenza virus vaccine, live, attenuated, for intranasal use
  53   112 http://hl7.org/fhir/sid/cvx typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) tetanus toxoid, unspecified formulation typhoid, parenteral, AKD (U.S. military) tetanus toxoid, unspecified formulation
  101   113 http://hl7.org/fhir/sid/cvx typhoid Vi capsular polysaccharide vaccine Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed typhoid, ViCPs tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
  75   114 http://hl7.org/fhir/sid/cvx vaccinia (smallpox) vaccine meningococcal MCV4P vaccinia (smallpox) meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
  105   115 http://hl7.org/fhir/sid/cvx vaccinia (smallpox) vaccine, diluted Tdap vaccinia (smallpox) diluted tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
  79   116 http://hl7.org/fhir/sid/cvx vaccinia immune globulin rotavirus, pentavalent rotavirus, live, pentavalent vaccine
  21   117 http://hl7.org/fhir/sid/cvx varicella virus vaccine VZIG (IND) varicella zoster immune globulin (Investigational New Drug)
  81   118 http://hl7.org/fhir/sid/cvx Venezuelan equine encephalitis, inactivated HPV, bivalent VEE, inactivated human papilloma virus vaccine, bivalent
  80   119 http://hl7.org/fhir/sid/cvx Venezuelan equine encephalitis, live, attenuated rotavirus, monovalent VEE, live rotavirus, live, monovalent vaccine
  92   120 http://hl7.org/fhir/sid/cvx Venezuelan equine encephalitis vaccine, unspecified formulation DTaP-Hib-IPV VEE, unspecified formulation diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
  36   121 http://hl7.org/fhir/sid/cvx varicella zoster immune globulin VZIG   117 http://hl7.org/fhir/sid/cvx live varicella zoster immune globulin (Investigational New Drug) VZIG (IND) vaccine, live
  37   122 http://hl7.org/fhir/sid/cvx yellow fever vaccine rotavirus, unspecified formulation yellow fever rotavirus vaccine, unspecified formulation
  121   123 http://hl7.org/fhir/sid/cvx zoster vaccine, live influenza, H5N1-1203 zoster live influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
  998   125 http://hl7.org/fhir/sid/cvx no vaccine administered Novel Influenza-H1N1-09, nasal Novel Influenza-H1N1-09, live virus for nasal administration
  999   126 http://hl7.org/fhir/sid/cvx unknown vaccine or immune globulin Novel influenza-H1N1-09, preservative-free unknown Novel influenza-H1N1-09, preservative-free, injectable
  99   127 http://hl7.org/fhir/sid/cvx RESERVED - do not use Novel influenza-H1N1-09 Novel influenza-H1N1-09, injectable
  133   128 http://hl7.org/fhir/sid/cvx pneumococcal conjugate vaccine, 13 valent Novel Influenza-H1N1-09, all formulations Pneumococcal conjugate PCV 13 Novel influenza-H1N1-09, all formulations
  134   129 http://hl7.org/fhir/sid/cvx Japanese Encephalitis vaccine for intramuscular administration Encephalitis, unspecified formulation Japanese Encephalitis IM   137 http://hl7.org/fhir/sid/cvx HPV, vaccine, unspecified formulation
  136   130 http://hl7.org/fhir/sid/cvx meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) DTaP-IPV Meningococcal MCV4O Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
  135   131 http://hl7.org/fhir/sid/cvx http://hl7.org/fhir/sid/cvx typhus, historical Historical record of a typhus vaccination
  132 http://hl7.org/fhir/sid/cvx DTaP-IPV-HIB-HEP B, historical Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
  128   133 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09, all formulations Pneumococcal conjugate PCV 13 Novel Influenza-H1N1-09, all formulations pneumococcal conjugate vaccine, 13 valent
  125   134 http://hl7.org/fhir/sid/cvx Novel Influenza-H1N1-09, live virus Japanese Encephalitis IM Japanese Encephalitis vaccine for nasal intramuscular administration
  135 Novel Influenza-H1N1-09, nasal http://hl7.org/fhir/sid/cvx Influenza, high dose seasonal influenza, high dose seasonal, preservative-free
  126   136 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09, preservative-free, injectable Meningococcal MCV4O Novel influenza-H1N1-09, preservative-free meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
  127   137 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09, injectable HPV, unspecified formulation Novel influenza-H1N1-09 HPV, unspecified formulation
  138 http://hl7.org/fhir/sid/cvx Td (adult) tetanus and diphtheria toxoids, not adsorbed, for adult use
  139 http://hl7.org/fhir/sid/cvx Td(adult) unspecified formulation Td(adult) unspecified formulation
  140 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable, preservative free http://hl7.org/fhir/sid/cvx Japanese Encephalitis vaccine, unspecified formulation Japanese Encephalitis, unspecified formulation Influenza, seasonal, injectable, preservative free
  141 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable Influenza, seasonal, injectable
  142 http://hl7.org/fhir/sid/cvx tetanus toxoid, not adsorbed tetanus toxoid, not adsorbed
  143 http://hl7.org/fhir/sid/cvx Adenovirus types 4 and 7 Adenovirus, type 4 and type 7, live, oral
  144 http://hl7.org/fhir/sid/cvx seasonal influenza, seasonal, intradermal, preservative free seasonal influenza, seasonal, intradermal, preservative free
  145 http://hl7.org/fhir/sid/cvx RSV-MAb (new) respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
  146 http://hl7.org/fhir/sid/cvx DTaP,IPV,Hib,HepB Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
  147 http://hl7.org/fhir/sid/cvx meningococcal MCV4, unspecified formulation Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
  148 http://hl7.org/fhir/sid/cvx Meningococcal C/Y-HIB PRP Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
  149 http://hl7.org/fhir/sid/cvx influenza, live, intranasal, quadrivalent influenza, live, intranasal, quadrivalent
  150 http://hl7.org/fhir/sid/cvx Influenza, influenza, injectable, quadrivalent, preservative free influenza, Influenza, injectable, quadrivalent, preservative free
  151 http://hl7.org/fhir/sid/cvx influenza nasal, unspecified formulation influenza nasal, unspecified formulation
  152 http://hl7.org/fhir/sid/cvx Pneumococcal Conjugate, unspecified formulation Pneumococcal Conjugate, unspecified formulation
  153 http://hl7.org/fhir/sid/cvx Influenza, injectable, Madin Darby Canine Kidney, MDCK, preservative free Influenza, injectable, MDCK, Madin Darby Canine Kidney, preservative free
  154 http://hl7.org/fhir/sid/cvx Hep A, IG Hepatitis A immune globulin
  155 http://hl7.org/fhir/sid/cvx Seasonal, trivalent, influenza, recombinant, injectable influenza vaccine, injectable, preservative free influenza, Seasonal, trivalent, recombinant, injectable, injectable influenza vaccine, preservative free
  156 http://hl7.org/fhir/sid/cvx Rho(D)-IG Rho(D) Immune globulin- IV or IM
  157 http://hl7.org/fhir/sid/cvx Rho(D) Immune globulin - -IG IM Rho(D) -IG Immune globulin - IM
  158 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent, contains preservative quadrivalent influenza, injectable, quadrivalent quadrivalent, contains preservative
  159 http://hl7.org/fhir/sid/cvx Rho(D) - Unspecified formulation Rho(D) - Unspecified formulation
  160 http://hl7.org/fhir/sid/cvx Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 ADJUVANTED-2013 Influenza A monovalent (H5N1), ADJUVANTED-2013   801 http://hl7.org/fhir/sid/cvx AS03 Adjuvant adjuvanted, National stockpile 2013
  161 http://hl7.org/fhir/sid/cvx Influenza, injectable,quadrivalent, preservative free, pediatric Influenza, injectable,quadrivalent, preservative free, pediatric
  162 http://hl7.org/fhir/sid/cvx meningococcal B vaccine, fully B, recombinant meningococcal B, B vaccine, fully recombinant
  163 http://hl7.org/fhir/sid/cvx meningococcal B, OMV meningococcal B vaccine, recombinant, OMV, adjuvanted
  164 http://hl7.org/fhir/sid/cvx meningococcal B, unspecified formulation meningococcal B, unspecified formulation
  165 http://hl7.org/fhir/sid/cvx HPV9 Human Papillomavirus 9-valent vaccine
  166 http://hl7.org/fhir/sid/cvx influenza, intradermal, quadrivalent, preservative free, injectable free influenza, intradermal, quadrivalent, preservative free free, injectable
  167 http://hl7.org/fhir/sid/cvx meningococcal, unknown serogroups meningococcal vaccine of unknown formulation and unknown serogroups
  168 http://hl7.org/fhir/sid/cvx influenza, trivalent, adjuvanted Seasonal trivalent influenza vaccine, adjuvanted, preservative free
  169 http://hl7.org/fhir/sid/cvx Hep A, live attenuated-IM attenuated Hep A, live attenuated attenuated-IM
  170 http://hl7.org/fhir/sid/cvx DTAP/IPV/HIB - non-US non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
  171 http://hl7.org/fhir/sid/cvx Influenza, injectable, Madin Darby Canine Kidney, MDCK, preservative free, quadrivalent Influenza, injectable, MDCK, Madin Darby Canine Kidney, preservative free, quadrivalent
  172 http://hl7.org/fhir/sid/cvx cholera, WC-rBS cholera, WC-rBS
  173 http://hl7.org/fhir/sid/cvx cholera, BivWC cholera, BivWC
  174 http://hl7.org/fhir/sid/cvx cholera, live attenuated cholera, live attenuated
  175 http://hl7.org/fhir/sid/cvx Human Rabies vaccine from human diploid - IM Diploid cell culture Human Rabies - IM Diploid vaccine from human diploid cell culture
  176 http://hl7.org/fhir/sid/cvx Rabies - IM fibroblast culture Human rabies vaccine from Chicken fibroblast culture
  177 http://hl7.org/fhir/sid/cvx PCV10 pneumococcal conjugate vaccine, 10 valent
  178 http://hl7.org/fhir/sid/cvx OPV bivalent Non-US bivalent oral polio vaccine (types 1 and 3)
  179 http://hl7.org/fhir/sid/cvx OPV ,monovalent, unspecified Non-US monovalent oral polio vaccine, unspecified formulation
  180 http://hl7.org/fhir/sid/cvx tetanus immune globulin tetanus immune globulin
  181 http://hl7.org/fhir/sid/cvx anthrax immune globulin anthrax immune globulin
  182 http://hl7.org/fhir/sid/cvx OPV, Unspecified Oral Polio Vaccine, Unspecified formulation
  183 http://hl7.org/fhir/sid/cvx Yellow fever vaccine alternative formulation - alt Yellow fever vaccine - alt alternative formulation
  184 http://hl7.org/fhir/sid/cvx Yellow fever vaccine, fever, unspecified formulation Yellow fever, fever vaccine, unspecified formulation
  185 http://hl7.org/fhir/sid/cvx Seasonal, quadrivalent, influenza, recombinant, injectable influenza vaccine, quadrivalent,injectable, preservative free influenza, Seasonal, quadrivalent, recombinant, quadrivalent,injectable, injectable influenza vaccine, preservative free
  186 http://hl7.org/fhir/sid/cvx Influenza, injectable, MDCK, quadrivalent, preservative Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative
  187 http://hl7.org/fhir/sid/cvx zoster vaccine recombinant zoster vaccine recombinant
  188 http://hl7.org/fhir/sid/cvx zoster vaccine, zoster, unspecified formulation zoster, zoster vaccine, unspecified formulation
  189 http://hl7.org/fhir/sid/cvx HepB-CpG Hepatitis B vaccine (recombinant), CpG adjuvanted
  190 http://hl7.org/fhir/sid/cvx Typhoid conjugate vaccine (non-US) (TCV) Typhoid conjugate vaccine (TCV) (non-US)
  191 http://hl7.org/fhir/sid/cvx meningococcal A polysaccharide vaccine (non-US) meningococcal A polysaccharide vaccine (non-US)
  192 http://hl7.org/fhir/sid/cvx meningococcal AC polysaccharide vaccine (non-US) meningococcal AC polysaccharide vaccine (non-US)
  193 http://hl7.org/fhir/sid/cvx Hep A-Hep B, pediatric/adolescent hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
  194 http://hl7.org/fhir/sid/cvx Influenza, Southern Hemisphere influenza, Southern Hemisphere, unspecified formulation
  195 http://hl7.org/fhir/sid/cvx Diphtheria, Tetanus, Poliomyelitis DT, IPV adsorbed DT, IPV Diphtheria, Tetanus, Poliomyelitis adsorbed
  196 http://hl7.org/fhir/sid/cvx tetanus and diphtheria toxoids, Td, adsorbed, preservative free, for adult use, Lf unspecified Td, tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
  197 http://hl7.org/fhir/sid/cvx influenza, high-dose, quadrivalent influenza, high-dose seasonal, quadrivalent, .7mL 0.7mL dose, preservative free
  198 influenza, high-dose, quadrivalent http://hl7.org/fhir/sid/cvx DTP-hepB-Hib Pentavalent Non-US Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
  200 http://hl7.org/fhir/sid/cvx influenza, Southern Hemisphere, pediatric, preservative free influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
  201 http://hl7.org/fhir/sid/cvx influenza, Southern Hemisphere, pediatric, preservative free influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative
  201   202 http://hl7.org/fhir/sid/cvx influenza, Southern Hemisphere, quadrivalent, with preservative influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no with preservative
  203 influenza, Southern Hemisphere, http://hl7.org/fhir/sid/cvx meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free
  202   204 http://hl7.org/fhir/sid/cvx Ebola Zaire vaccine, live, recombinant, 1mL dose Ebola Zaire vaccine, live, recombinant, 1mL dose
  205 http://hl7.org/fhir/sid/cvx Influenza vaccine, quadrivalent, adjuvanted influenza, seasonal, Southern Hemisphere, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, with preservative free
  206 influenza, Southern Hemisphere, quadrivalent, with http://hl7.org/fhir/sid/cvx Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection
  198   207 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
  208 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
  210 Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) http://hl7.org/fhir/sid/cvx COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
  211 DTP-hepB-Hib Pentavalent Non-US http://hl7.org/fhir/sid/cvx COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose
  212 http://hl7.org/fhir/sid/cvx COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL
  203   213 http://hl7.org/fhir/sid/cvx SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
  214 http://hl7.org/fhir/sid/cvx Ebola, unspecified Ebola, unspecified
  215 meningococcal http://hl7.org/fhir/sid/cvx Pneumococcal conjugate PCV15, polysaccharide (groups A, C, Y, W-135) tetanus toxoid CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine .5mL dose, 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free
  216 meningococcal http://hl7.org/fhir/sid/cvx Pneumococcal conjugate PCV20, polysaccharide (groups A, C, Y, W-135) TT CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free
  205   217 http://hl7.org/fhir/sid/cvx influenza, seasonal COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, quadrivalent, adjuvanted, .5mL mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation
  218 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free free, 10 mcg/0.2mL dose, tris-sucrose formulation
  219 Influenza http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, quadrivalent, adjuvanted mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation
  220 http://hl7.org/fhir/sid/cvx HepB recombinant, 3-antigen, Al(OH)3 Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted
  206   221 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
  222 http://hl7.org/fhir/sid/cvx Tick-borne encephalitis, unspecified Tick-borne encephalitis vaccine, unspecified
  223 smallpox monkeypox http://hl7.org/fhir/sid/cvx Tick-borne encephalitis, inactivated, PF, 0.25mL Tick-borne encephalitis vaccine, live attenuated, inactivated, preservative free (National Stockpile) free, 0.25mL dose
  224 Smallpox monkeypox vaccine (National Stockpile) http://hl7.org/fhir/sid/cvx Tick-borne encephalitis, inactivated, PF, 0.5mL Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose
  225 http://hl7.org/fhir/sid/cvx COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose
  207   226 http://hl7.org/fhir/sid/cvx COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose
  227 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose
  228 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL pediatric 25 mcg/0.25 mL dose
  229 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, bivalent, PF, 100 50 mcg/0.5 mL or 25mcg/0.25 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose
  208   230 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3mL 10 mcg/0.2 mL dose
  231 http://hl7.org/fhir/sid/cvx influenza, Southern Hemisphere, high-dose, quadrivalent influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free
  300 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
  213   301 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation
  302 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation
  303 http://hl7.org/fhir/sid/cvx RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free
  304 http://hl7.org/fhir/sid/cvx Respiratory syncytial virus (RSV), unspecified Respiratory syncytial virus (RSV), unspecified
  305 http://hl7.org/fhir/sid/cvx RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free
  210   306 http://hl7.org/fhir/sid/cvx RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months
  307 http://hl7.org/fhir/sid/cvx RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months
  308 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant mRNA, spike protein-ChAdOx1, protein, LNP, preservative free, 0.5 tris-sucrose, 3 mcg/0.3 mL dose
  309 COVID-19 vaccine, vector-nr, rS-ChAdOx1, http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 0.5 tris-sucrose, 30 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose
  310 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose
  212   311 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose
  312 http://hl7.org/fhir/sid/cvx COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
  313 http://hl7.org/fhir/sid/cvx COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, subunit, recombinant spike protein-Ad26, protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5 ml 5 mcg/0.5 mL dose
  314 COVID-19 http://hl7.org/fhir/sid/cvx Respiratory syncytial virus (RSV) vaccine, unspecified Respiratory syncytial virus (RSV) vaccine, unspecified
  315 http://hl7.org/fhir/sid/cvx Respiratory syncytial virus (RSV) MAB, unspecified Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified
  316 http://hl7.org/fhir/sid/cvx meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free
  317 http://hl7.org/fhir/sid/cvx Chikungunya live attenuated vaccine, vector-nr, rS-Ad26, PF, 0.5 mL mL, PF Chikungunya, live attenuated vaccine, 0.5 mL, preservative free
  500 http://hl7.org/fhir/sid/cvx COVID-19 Non-US Vaccine, Product Unknown SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown
  204   501 http://hl7.org/fhir/sid/cvx COVID-19 IV Non-US Vaccine (QAZCOVID-IN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)
  502 http://hl7.org/fhir/sid/cvx COVID-19 IV Non-US Vaccine (COVAXIN) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)
  503 Ebola Zaire vaccine, live, recombinant, 1mL dose http://hl7.org/fhir/sid/cvx COVID-19 LAV Non-US Vaccine (COVIVAC) SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)
  504 http://hl7.org/fhir/sid/cvx COVID-19 VVnr Non-US Vaccine (Sputnik Light) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)
  505 http://hl7.org/fhir/sid/cvx COVID-19 VVnr Non-US Vaccine (Sputnik V) SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)
  506 http://hl7.org/fhir/sid/cvx COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology
  214   507 http://hl7.org/fhir/sid/cvx COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)
  508 http://hl7.org/fhir/sid/cvx COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)
  509 Ebola, unspecified http://hl7.org/fhir/sid/cvx COVID-19 PS Non-US Vaccine (EpiVacCorona) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)
  510 http://hl7.org/fhir/sid/cvx COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)
  511 http://hl7.org/fhir/sid/cvx COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)
  512 http://hl7.org/fhir/sid/cvx SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)
  211   513 http://hl7.org/fhir/sid/cvx SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)
  514 http://hl7.org/fhir/sid/cvx SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)
  515 http://hl7.org/fhir/sid/cvx SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)
  516 http://hl7.org/fhir/sid/cvx COV-2 COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
  517 http://hl7.org/fhir/sid/cvx SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)
  AGRPAL   518 http://hl7.org/fhir/sid/cvx COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
  519 urn:oid:1.2.36.1.2001.1005.17 http://hl7.org/fhir/sid/cvx COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
  520 Agrippal http://hl7.org/fhir/sid/cvx COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech
  521 http://hl7.org/fhir/sid/cvx COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK
  801 http://hl7.org/fhir/sid/cvx AS03 Adjuvant AS03 Adjuvant
  998 http://hl7.org/fhir/sid/cvx no vaccine administered no vaccine administered
  AVAXM   999 http://hl7.org/fhir/sid/cvx unknown unknown vaccine or immune globulin
  AGRPAL urn:oid:1.2.36.1.2001.1005.17 Agrippal
  AVAXM urn:oid:1.2.36.1.2001.1005.17 Avaxim
  BCG urn:oid:1.2.36.1.2001.1005.17 BCG
  CDT urn:oid:1.2.36.1.2001.1005.17 CDT
  CMX urn:oid:1.2.36.1.2001.1005.17 COMVAX
  DTP urn:oid:1.2.36.1.2001.1005.17 Triple Antigen
  DTPA urn:oid:1.2.36.1.2001.1005.17 DTPa
  ENGP urn:oid:1.2.36.1.2001.1005.17 Engerix B
  FLRIX urn:oid:1.2.36.1.2001.1005.17 Fluarix
  FLUVAX urn:oid:1.2.36.1.2001.1005.17 Fluvax
  FLVRN urn:oid:1.2.36.1.2001.1005.17 Fluvirin
  FVXJNR urn:oid:1.2.36.1.2001.1005.17 Fluvax Junior
  GNDIP urn:oid:1.2.36.1.2001.1005.17 Diphtheria
  GNFLU urn:oid:1.2.36.1.2001.1005.17 Influenza
  GNHEP urn:oid:1.2.36.1.2001.1005.17 Hepatitis B
  GNHIB urn:oid:1.2.36.1.2001.1005.17 HIB
  GNHPA urn:oid:1.2.36.1.2001.1005.17 Hepatitis A
  GNJEN urn:oid:1.2.36.1.2001.1005.17 Japanese Encephalitis
  GNMEA urn:oid:1.2.36.1.2001.1005.17 Measles
  GNMEN urn:oid:1.2.36.1.2001.1005.17 Meningococcal C
  GNMUM urn:oid:1.2.36.1.2001.1005.17 Mumps
  GNPNE urn:oid:1.2.36.1.2001.1005.17 Pneumococcal
  GNPOL urn:oid:1.2.36.1.2001.1005.17 Polio
  GNROX urn:oid:1.2.36.1.2001.1005.17 Rotavirus
  GNRUB urn:oid:1.2.36.1.2001.1005.17 Rubella
  GNTET urn:oid:1.2.36.1.2001.1005.17 Tetanus
  GNVAR urn:oid:1.2.36.1.2001.1005.17 Varicella
  HATWNJ urn:oid:1.2.36.1.2001.1005.17 Twinrix Junior
  HAVAQ urn:oid:1.2.36.1.2001.1005.17 Vaqta Paed/Adol
  HAVJ urn:oid:1.2.36.1.2001.1005.17 Havrix Junior
  HBOC urn:oid:1.2.36.1.2001.1005.17 HibTITER
  HBV urn:oid:1.2.36.1.2001.1005.17 HBV
  HBVP urn:oid:1.2.36.1.2001.1005.17 HBVAX II
  HBX urn:oid:1.2.36.1.2001.1005.17 Hiberix
  IFHX urn:oid:1.2.36.1.2001.1005.17 Infanrix Hexa
  IFIP urn:oid:1.2.36.1.2001.1005.17 Infanrix-IPV
  IFPA urn:oid:1.2.36.1.2001.1005.17 Infanrix Penta
  IFX urn:oid:1.2.36.1.2001.1005.17 Infanrix
  IFXB urn:oid:1.2.36.1.2001.1005.17 InfanrixHepB
  INFLUV urn:oid:1.2.36.1.2001.1005.17 Influvac
  IPV urn:oid:1.2.36.1.2001.1005.17 IPOL
  JEVAX urn:oid:1.2.36.1.2001.1005.17 JE-VAX
  MENJUG urn:oid:1.2.36.1.2001.1005.17 Menjugate
  MENTEC urn:oid:1.2.36.1.2001.1005.17 Meningitec
  MENUME urn:oid:1.2.36.1.2001.1005.17 Menomune
  MENVAX urn:oid:1.2.36.1.2001.1005.17 Mencevax ACWY
  MMR urn:oid:1.2.36.1.2001.1005.17 MMR
  MMRCSL urn:oid:1.2.36.1.2001.1005.17 MMR II
  MMRSKB urn:oid:1.2.36.1.2001.1005.17 Priorix
  MNTRX urn:oid:1.2.36.1.2001.1005.17 Menitorix
  NEISVC urn:oid:1.2.36.1.2001.1005.17 NeisVac-C
  OPV urn:oid:1.2.36.1.2001.1005.17 Polio
  P urn:oid:1.2.36.1.2001.1005.17 Pertussis
  PANVAX urn:oid:1.2.36.1.2001.1005.17 Panvax
  PDCL urn:oid:1.2.36.1.2001.1005.17 Pediacel
  PLCL urn:oid:1.2.36.1.2001.1005.17 Poliacel
  PNEUMO urn:oid:1.2.36.1.2001.1005.17 Pneumovax
  PRPD urn:oid:1.2.36.1.2001.1005.17 ProHIBit
  PROQAD urn:oid:1.2.36.1.2001.1005.17 ProQuad
  PRPOMP urn:oid:1.2.36.1.2001.1005.17 PedvaxHIB
  PRPT urn:oid:1.2.36.1.2001.1005.17 ActHIB
  PRVNR urn:oid:1.2.36.1.2001.1005.17 Prevenar 7
  PRVTH urn:oid:1.2.36.1.2001.1005.17 Prevenar 13
  PRXTEX urn:oid:1.2.36.1.2001.1005.17 Priorix-Tetra
  QDCL urn:oid:1.2.36.1.2001.1005.17 Quadracel
  ROTRIX urn:oid:1.2.36.1.2001.1005.17 Rotarix
  ROTTEQ urn:oid:1.2.36.1.2001.1005.17 Rotateq
  SYNFLX urn:oid:1.2.36.1.2001.1005.17 Synflorix
  TCL urn:oid:1.2.36.1.2001.1005.17 Tripacel
  VAXGRP urn:oid:1.2.36.1.2001.1005.17 Vaxigrip
  VGRJNR urn:oid:1.2.36.1.2001.1005.17 Vaxigrip Junior
  VLRIX urn:oid:1.2.36.1.2001.1005.17 Varilrix
  VRVAX urn:oid:1.2.36.1.2001.1005.17 Varivax

 

See the full registry of value sets defined as part of FHIR.


Explanation of the columns that may appear on this page:

Lvl A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
Display The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code